These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27473943)

  • 21. Leptin levels and its correlation with crack-cocaine use severity: A preliminary study.
    Escobar M; Scherer JN; Ornell F; Bristot G; Soares CM; Guimarães LSP; Von Diemen L; Pechansky F
    Neurosci Lett; 2018 Apr; 671():56-59. PubMed ID: 29421542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adipokines during early abstinence of crack cocaine in dependent women reporting childhood maltreatment.
    Levandowski ML; Viola TW; Tractenberg SG; Teixeira AL; Brietzke E; Bauer ME; Grassi-Oliveira R
    Psychiatry Res; 2013 Dec; 210(2):536-40. PubMed ID: 23896356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinct behavioral and immunoendocrine parameters during crack cocaine abstinence in women reporting childhood abuse and neglect.
    Levandowski ML; Viola TW; Prado CH; Wieck A; Bauer ME; Brietzke E; Grassi-Oliveira R
    Drug Alcohol Depend; 2016 Oct; 167():140-8. PubMed ID: 27530287
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain-derived neurotrophic factor serum levels as a candidate biomarker for withdrawal in crack heroin dependence.
    Charkhat Gorgich EA; Rigi MG; Fanaei H; Parsaei H; Ghanbarzehi A
    Subst Abuse Treat Prev Policy; 2024 Jan; 19(1):9. PubMed ID: 38245698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased cortisol levels are associated with low treatment retention in crack cocaine users.
    Ligabue KP; Schuch JB; Scherer JN; Ornell F; Roglio VS; Assunção V; Rebelatto FP; Hildalgo MP; Pechansky F; Kessler F; von Diemen L
    Addict Behav; 2020 Apr; 103():106260. PubMed ID: 31901885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic heroin and cocaine abuse is associated with decreased serum concentrations of the nerve growth factor and brain-derived neurotrophic factor.
    Angelucci F; Ricci V; Pomponi M; Conte G; Mathé AA; Attilio Tonali P; Bria P
    J Psychopharmacol; 2007 Nov; 21(8):820-5. PubMed ID: 17715210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crack users show high rates of antisocial personality disorder, engagement in illegal activities and other psychosocial problems.
    Paim Kessler FH; Barbosa Terra M; Faller S; Ravy Stolf A; Carolina Peuker A; Benzano D; ; Pechansky F
    Am J Addict; 2012; 21(4):370-80. PubMed ID: 22691017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concurrent use and order of use of cocaine and alcohol: behavioural differences between users of crack cocaine and cocaine powder.
    Gossop M; Manning V; Ridge G
    Addiction; 2006 Sep; 101(9):1292-8. PubMed ID: 16911728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Crack Cocaine Use in Adolescents: Clinical Characteristics and Predictors of Early Initiation.
    Pianca TG; Rohde LA; Rosa RL; Begnis AP; Ferronatto PB; Jensen MC; Pechansky F; Ceresér KM; Fairchild VP; Szobot CM
    J Clin Psychiatry; 2016 Oct; 77(10):e1205-e1210. PubMed ID: 27574840
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of neuropeptide Y levels is impaired in crack withdrawal patients.
    Galland F; Schuch JB; Silvello D; Ligabue K; Hansen F; Scherer JN; Sordi AO; von Diemen L
    Trends Psychiatry Psychother; 2020 Jun; 42(2):147-152. PubMed ID: 32696889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modafinil in the treatment of crack-cocaine dependence in the Netherlands: Results of an open-label randomised controlled feasibility trial.
    Nuijten M; Blanken P; van den Brink W; Hendriks V
    J Psychopharmacol; 2015 Jun; 29(6):678-87. PubMed ID: 25922424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Criminal justice involvement of crack cocaine users in the city of Rio de Janeiro and Greater Metropolitan Area: Implications for public health and the public security agenda.
    Toledo L; Cano I; Bastos L; Bertoni N; Bastos FI
    Int J Drug Policy; 2017 Nov; 49():65-72. PubMed ID: 28961496
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early abstinence of crack-cocaine is effective to attenuate oxidative stress and to improve antioxidant defences.
    Zaparte A; Viola TW; Grassi-Oliveira R; da Silva Morrone M; Moreira JC; Bauer ME
    Psychopharmacology (Berl); 2015 Apr; 232(8):1405-13. PubMed ID: 25338778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-6 and IL-10 levels in the umbilical cord blood of newborns with a history of crack/cocaine exposure in utero: a comparative study.
    Mardini V; Rohde LA; Ceresér KM; Gubert Cde M; da Silva EG; Xavier F; Parcianello R; Röhsig LM; Pechansky F; Pianca TG; Szobot CM
    Trends Psychiatry Psychother; 2016; 38(1):40-9. PubMed ID: 27074340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of cytokines, oxidative stress markers and brain-derived neurotrophic factor in patients with fibromyalgia - A controlled cross-sectional study.
    Ranzolin A; Duarte AL; Bredemeier M; da Costa Neto CA; Ascoli BM; Wollenhaupt-Aguiar B; Kapczinski F; Xavier RM
    Cytokine; 2016 Aug; 84():25-8. PubMed ID: 27209553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Accumbens volumes are reduced among crack-cocaine users.
    Schuch-Goi SB; Goi PD; Bermudez M; Fara LS; Kessler FP; Pechansky F; Gama CS; Massuda R; von Diemen L
    Neurosci Lett; 2017 Apr; 645():86-89. PubMed ID: 28259655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hair cortisol and stressful life events retrospective assessment in crack cocaine users.
    Grassi-Oliveira R; Pezzi JC; Daruy-Filho L; Viola TW; Francke ID; Leite CE; Brietzke E
    Am J Drug Alcohol Abuse; 2012 Nov; 38(6):535-8. PubMed ID: 22746544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predictors of early relapse among adolescent crack users.
    Lopes-Rosa R; Kessler FP; Pianca TG; Guimarães L; Ferronato P; Pagnussat E; Moura H; Pechansky F; von Diemen L
    J Addict Dis; 2017; 36(2):136-143. PubMed ID: 28296627
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peripheral neurotrophin levels during controlled crack/cocaine abstinence: a systematic review and meta-analysis.
    Morelos-Santana E; Islas-Preciado D; Alcalá-Lozano R; González-Olvera J; Estrada-Camarena E
    Sci Rep; 2024 Jan; 14(1):1410. PubMed ID: 38228745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased electroencephalographic activity in crack-cocaine users visualizing crack cues.
    Moscon JA; Conti CL; Nakamura-Palacios EM
    J Psychiatr Res; 2016 Dec; 83():137-139. PubMed ID: 27614336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.